HealthEquity Inc. reported adjusted second-quarter earnings of $1.24 per share, exceeding the $1.19 estimate by $0.05. Revenue totaled $350.73 million, surpassing the $349.22 million consensus.
The company also provided fiscal 2027 guidance, projecting adjusted earnings of $4.66 to $4.73 per share, slightly below the $4.72 consensus. Revenue is forecasted between $1.41 billion and $1.42 billion, matching the $1.41 billion estimate.
HealthEquity’s stock closed at $104.42, up 18.67% over the past three months and 18.27% year-over-year. Analyst revisions in the last 90 days have been mixed, with six positive EPS adjustments and seven negative ones.
The company’s performance was described by InvestingPro as "great performance," reflecting strong operational execution in its health savings account platform.
